IL6 and pulmonary fibrosis: Whereas IL-6-neutralizing antibodies ameliorate lung fibrosis at early fibrotic stages of BLM-induced lung injury, blockade of the IL-6 pathway accelerates the development of lung fibrosis at the early inflammatory stage in the BLM-induced PF mice model [22].